search
Back to results

Effects of Lactose on Fecal Microflora (ELM)

Primary Purpose

Lactose Intolerance

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
lactose
lactose
Sponsored by
Sir Mortimer B. Davis - Jewish General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Lactose Intolerance focused on measuring lactase, lactose, microflora

Eligibility Criteria

18 Years - 49 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 18-49 yr old male or female.
  • Healthy except may take chronic thyroid or hypertension medication.

Exclusion Criteria:

  • Pregnancy
  • Antibiotics in last 6 weeks
  • Any active illness.

Sites / Locations

  • Sir Mortimer B Davis General Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

1

2

Arm Description

Participants in arm 1 are grouped as lactose digesters based on genetic analysis and breath hydrogen results. In discrepant cases the genetic status is accepted. Arm 1 is initially withdrawn from dairy foods(lactose) and then asked to consume lactose 50g in divided doses mixed in water for 2 weeks.

Arm 2 are lactose maldigesters: 2 interventions are a. withdrawal from lactose for 2 weeks and b. consumption of 50g lactose in divided doses mixed in water for a 2 week period.

Outcomes

Primary Outcome Measures

bacterial differences within the 2 groups between the 2 weeks of lactose ingestion

Secondary Outcome Measures

bacterial differences between the 2 groups on comparison of first stool sample

Full Information

First Posted
January 10, 2008
Last Updated
September 18, 2009
Sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Collaborators
Danone Institute International
search

1. Study Identification

Unique Protocol Identification Number
NCT00599859
Brief Title
Effects of Lactose on Fecal Microflora
Acronym
ELM
Official Title
Differential Biologic Impact of Lactose Consumption in Lactase Persistent and Non-persistent Populations: Evaluation of Microflora and Insulin/Glycemic Response
Study Type
Interventional

2. Study Status

Record Verification Date
September 2009
Overall Recruitment Status
Completed
Study Start Date
September 2006 (undefined)
Primary Completion Date
August 2008 (Actual)
Study Completion Date
August 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Collaborators
Danone Institute International

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The genetics of lactase divides the population into 2 phenotypes: Those who can(LP) and those who cannot(LNP)digest lactose. This division may help modify disease risks according to geographic population distribution. At least some of the putative mechanism of risk modification may relate to an effect of undigested lactose on lower intestinal bacteria. The effect may provide for support of beneficial microbes. The amount of lactose reaching the colon is made easier in LNP than LP subjects who have to consume larger amounts to have meaningful spillover into the lower bowel.The current study examines whether there are quantifiable qualitative fecal bacterial differences to a standard intake of lactose(milk sugar)between these 2 different phenotypic populations. Finding of differences would lend support to the notion that for some diseases LP and LNP subjects face different risks even in an area of uniform disease risk if they consume lactose (found in dairy foods). The primary end point is comparison of 4 groups of specific bacteria between LP and LNP participants before and after 2 weeks of lactose(in powder form mixed in water) consumption. Classification is based on genetic analysis and secondarily on breath hydrogen results. Results are compared within groups. The secondary outcome is comparison of 4 groups of bacteria between LP and LNP subjects against each group of stool samples obtained on the first visit. Results are obtained between groups. Additional information and other secondary outcomes are to evaluate any relationship between diet intake and the 4 groups of bacteria on the first visit Another outcome will be to compare within groups any effect of lactose consumption on insulin and glucose levels within the 2 groups.
Detailed Description
Healthy volunteers between the ages of 18 and 49 are recruited. Each participant fills a lactose targetting diet questionnaire(3 day recall). A 50g lactose challenge tets is administered,breath hydrogen and symptoms are recorded for 4.5hrs. Blood is drawn for analysis of lactase genetic status. A stool sample is collected(10-15g)and analysed fo total anaerobes, enterococci, bifidobacteria and lactobacilli. All subjects are withdrawn from dairy foods(calcium replacement suggested in diet) for 2 weeks and are aked to return to repeat parts 2 and 4. A voluntary segment has glucose and insulin measured for 4 hrs via an indwelling venous catheter. Subjects are asked to consume 50g lactose in divided doses for 2 further weeks At the end they return and repeat sections 2 and 4 for the third time. Participants who volunteered to have glucose and insulin measured repeat this segment of the study as well.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lactose Intolerance
Keywords
lactase, lactose, microflora

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Enrollment
57 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
Participants in arm 1 are grouped as lactose digesters based on genetic analysis and breath hydrogen results. In discrepant cases the genetic status is accepted. Arm 1 is initially withdrawn from dairy foods(lactose) and then asked to consume lactose 50g in divided doses mixed in water for 2 weeks.
Arm Title
2
Arm Type
Active Comparator
Arm Description
Arm 2 are lactose maldigesters: 2 interventions are a. withdrawal from lactose for 2 weeks and b. consumption of 50g lactose in divided doses mixed in water for a 2 week period.
Intervention Type
Dietary Supplement
Intervention Name(s)
lactose
Intervention Description
consumption of 50g lactose/day in 2 divided doses mixed in water.
Intervention Type
Dietary Supplement
Intervention Name(s)
lactose
Intervention Description
consumption of lactose 50g/day in 2 divided doses mixed in water
Primary Outcome Measure Information:
Title
bacterial differences within the 2 groups between the 2 weeks of lactose ingestion
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
bacterial differences between the 2 groups on comparison of first stool sample
Time Frame
1 day

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
49 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 18-49 yr old male or female. Healthy except may take chronic thyroid or hypertension medication. Exclusion Criteria: Pregnancy Antibiotics in last 6 weeks Any active illness.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andrew Szilagyi, MD
Organizational Affiliation
SMBD Jewish General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sir Mortimer B Davis General Hospital
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H3T 1E2
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
17044768
Citation
Szilagyi A, Nathwani U, Vinokuroff C, Correa JA, Shrier I. The effect of lactose maldigestion on the relationship between dairy food intake and colorectal cancer: a systematic review. Nutr Cancer. 2006;55(2):141-50. doi: 10.1207/s15327914nc5502_4.
Results Reference
background
PubMed Identifier
17044769
Citation
Szilagyi A, Nathwani U, Vinokuroff C, Correa JA, Shrier I. Evaluation of relationships among national colorectal cancer mortality rates, genetic lactase non-persistence status, and per capita yearly milk and milk product consumption. Nutr Cancer. 2006;55(2):151-6. doi: 10.1207/s15327914nc5502_5.
Results Reference
background

Learn more about this trial

Effects of Lactose on Fecal Microflora

We'll reach out to this number within 24 hrs